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Background: Atherosclerosis is considered to be a chronic inflammatory disease. Astragali Radix extract (ARE) is
one of the major active ingredients extracted from the root of Astragalus membranaceus Bge. Although ARE has an
anti-inflammatory function, its anti-atherosclerotic effects and mechanisms have not yet been elucidated.
Methods: Murine endothelial SVEC4-10 cells were pretreated with different doses of ARE at different times prior to
induction with tumor necrosis factor (TNF)-α. Cell adhesion assays were performed using THP-1 cells and assessed
by enzyme-linked immunosorbent assay, western blotting and immunofluorescence analyses to detect the
expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1),
phosphorylated inhibitor of κB (p-iκB) and nuclear factor (NF)-κB. We also examined the effect of ARE on
atherosclerosis in the aortic endothelium of apolipoprotein E-deficient (apoE−/−) mice.
Results: TNF-α strongly increased the expression of VCAM-1 and ICAM-1 accompanied by increased expression of p-iκB
and NF-κB proteins. However, the expression levels of VCAM-1 and ICAM-1 were reduced by ARE in dose- and
time-dependent manners, with the strongest effect at a dose of 120 μg/ml incubated for 4 h. This was
accompanied by significantly decreased expression of p-iκB and inhibited activation of NF-κB. Immunofluorescence
analysis also revealed that oral administration of ARE resulted in downregulation of adhesion molecules and
decreased expression of macrophages in the aortic endothelium of apoE−/− mice. ARE could suppress the
inflammatory reaction and inhibit the progression of atherosclerotic lesions in apoE−/− mice.
Conclusion: This study demonstrated that ARE might be an effective anti-inflammatory agent for the treatment of
atherosclerosis, possibly acting via the decreased expression of adhesion molecules.
Keywords: Astragali Radix extract, Vascular cell adhesion molecule-1, Vntercellular adhesion molecule-1,
Apolipoprotein E-deficient mice, AtherosclerosisBackground
Atherosclerosis is one of the most prevalent diseases in the
world and is characterized by multifactorial and multistep
processes. Atherosclerosis is known to be a chronic in-
flammatory disease, although its pathophysiological
mechanisms remain elusive [1]. The adhesion of circulat-
ing leukocytes to the endothelium is an important cellular* Correspondence: yalinghan@gmail.com
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reproduction in any medium, provided the orresponse to inflammation. Endothelial cells express an
array of adhesion molecules that mediate the process of
leukocyte attachment to the vascular wall during inflam-
mation [2]. Leukocyte-endothelium interactions require
regulation of the expression of various adhesion molecules
by endothelial cells, such as vascular cell adhesion mol-
ecule-1 (VCAM-1) and intercellular adhesion molecule-1
(ICAM-1) [3]. Proinflammatory mediators such as inter-
leukin-1 and tumor necrosis factor (TNF)-α can promote
the activation of endothelial cells in the early stages of the
inflammatory process. Activation on endothelial cells
results in increased expression of VCAM-1 and ICAM-1. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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endothelium at local sites of inflammation [4], and ultim-
ately resulting in the development of atherosclerosis. Vari-
ous inflammatory pathways have been implicated in
atherosclerosis, leading not only to the recruitment and
entry of inflammatory cells into the arterial wall, but also
to modification of the morphology and composition of
atherosclerotic plaques. Certain inflammatory pathways,
such as those involving VCAM-1, and ICAM-1, appear to
play an important role in lesion initiation [5-7].
The root of Astragalus membranaceus Bge is a common
Chinese medicinal herb. Several compounds isolated from
this plant, as well as the plant itself, have been reported to
show therapeutic potential in some diseases, such as
nephropathy, cardiac contractile dysfunction and open
wounds [8-10], and the root of A. membranaceus Bge was
been widely used for the treatment of cardiovascular dis-
eases in ancient China. Astragali Radix extract (ARE) is
one of the major active ingredients extracted from the root
of A. membranaceus Bge. Previous studies showed that
ARE had potential anti-inflammatory activity [9,11-14],
and recent evidence demonstrated that ARE could reduce
macrophage migration [15] and adhesion to endothelial
cells, and relieve local inflammation via a nuclear factor
(NF)-κB pathway [16-19]. However, the anti-atherosclerotic
effects of ARE and its mechanisms have not yet been
elucidated.
The present study therefore aimed to clarify the anti-
atherosclerotic effects and molecular mechanisms of
ARE by investigating its effects on the expression of ad-
hesion molecules in murine endothelial cells stimulated
with TNF-α, investigating its influences on the NF-κB
pathway, and assessing the progression of atherosclerotic
lesions and the expression of adhesion molecules in the




ARE was provided by the Dalian Institute of Chemical
Physics, Chinese Academy of Sciences (Dalian, China), and
dissolved and diluted in incubation medium to yield final
concentrations of 30-120 μg/ml. TNF-α was purchased
from Sigma-Aldrich (Saint Louis, MO, USA). Goat mono-
clonal anti-VCAM-1, goat monoclonal anti-ICAM-1,
mouse monoclonal NF-κB p65, mouse monoclonal phos-
phorylated inhibitor of κB (p-iκB)-α, goat polyclonal
Lamin B and anti-β-actin antibodies were purchased from
Santa Cruz (CA, USA). Rat anti-mouse Mac3 and rat
anti-mouse CD31 antibodies were purchased from BD
Pharmingen (San Diego, CA, USA). The mouse soluble
VCAM-1 immunoassay and mouse soluble ICAM-1 im-
munoassay kits were purchased from R&D Systems
(MN, USA). The enhanced chemiluminescence (ECL)western blotting system was from Amersham Biosciences
(Buckinghamshire, UK).
Endothelial cell culture and treatment
The murine endothelial cell line (SVEC4-10) was pur-
chased from the American Type Culture Collection (MD,
USA) and cultured in DMEM supplemented with 10 %
fetal calf serum (FCS, HyClone, UT, USA), 30 μg/ml endo-
thelial cell growth factor (Sigma-Aldrich, Saint Louis, MO,
USA), 5 U/ml heparin, 100 U/ml penicillin, and 100 U/ml
streptomycin at 37°C in an atmosphere of 5 % CO2 and
95 % air. The phenotype of SVEC cells was confirmed
morphologically and by positive immunofluorescence
staining of CD31. Cells were treated with 30, 60, or
120 μg/ml ARE in fresh serum-free medium and incubated
for 2, 4, 6, or 8 h.
Culture of THP-1 cells
THP-1 cells were purchased from the American Type
Culture Collection and grown in RPMI-1640 media
(Sigma) containing 10 % FCS, 100 μg/ml streptomycin,
100 IU/ml penicillin, 250 ng/ml fungizone, 1 mM glu-
tamine, 5 × 10–5 M 2-mercaptoethanol, and routinely
subcultured three times per week at a ratio of 1:5.
Mice
Male apoE−/− mice (n= 24, age 8 weeks, 18–20 g) on a
C57BL/6 J background were obtained from the Department
of Laboratory Animal Science, Peking University Health
Science Center, China. All mice were barrier housed, spe-
cific pathogen-free, and maintained in static microisolator
cages. Mice were fed a high-fat, high-cholesterol diet con-
taining 15 % fat and 0.25 % cholesterol. ApoE−/− mice were
randomized into either a control group or an ARE group
(n=12 for each group). ARE mice were given oral doses of
ARE (5 g/kg body weight per day). Blood and tissues were
collected at 24 weeks of age for further analysis. The care
and use of animals were performed in adherence with the
National Institutes of Health Guidelines, and all experi-
mental procedures involving animals were approved by the
Ethics Committee of Shenyang Northern Hospital.
Adhesion assay for THP-1 cells
SVEC cells were plated in six-well plates and allowed to
grow to confluence, as described above. The medium
was removed and the cells were then incubated with
1.0 ml/well DMEM medium containing 10 % FCS with
or without TNF-α (10 ng/ml) or TNF-α plus ARE at the
concentrations and incubation times indicated above.
Culture supernatant was removed from the treated cells
at the indicated time points, and the cells were gently
washed three times with DMEM medium. A volume of
1.0 ml of RPMI-1640 media containing 1 × 106 THP-1
cells was then added to the endothelial cell monolayers
You et al. BMC Complementary and Alternative Medicine 2012, 12:54 Page 3 of 11
http://www.biomedcentral.com/1472-6882/12/54in each well. The binding phase of the assay was per-
formed at 37°C in a 5 % CO2 atmosphere for 15 min for
THP-1 cells. Thereafter the wells were washed three
times with phosphate-buffered saline (PBS) (1.0 ml/well),
and all wells were examined under a microscope to de-
termine if any loss of endothelial cells had occurred dur-
ing incubation or washing. The number of THP-1 cells
washed in PBS was counted using a counting slide.
Experiments were performed in triplicate.Enzyme-linked immunosorbent assay (ELISA)
Aliquots of culture medium were collected from cells
treated as described above. VCAM-1 and ICAM-1 levels
in the culture medium were measured directly using an
ELISA kit (R&D Systems), according to the manufacturer’s
instructions. Standards containing known amounts of
recombinant VCAM-1 and ICAM-1 were also analyzed.
ELISA assay results were measured using a microplate
reader. Absorbance was measured spectrophotometrically
at 450 nm and plotted against a standard curve with
VCAM-1 and ICAM-1 levels expressed in ng/ml. Experi-
ments were performed in triplicate.Western blot analysis
Confluent cells were cultured in medium with or without
TNF-α (10 ng/ml) or TNF-α plus ARE at the concentra-
tions and the incubation times indicated above to detect
VCAM-1, ICAM-1, NF-κB, and p-iκB. Total proteins
were extracted with 100 μl of lysis buffer (50 mmol/l
Tris, 10 mmol/l MgCl2, 0.5 mol/l NaCl, 1 % Triton
X-100) supplemented with a protease inhibitor mixture
and 1 mmol/l phenylmethylsulfonyl fluoride. Cells were
maintained on ice and lysates were harvested by scrap-
ing. The supernatants were collected after centrifugation
at 14,000 g for 10 min. For nuclear protein analysis, cells
were resuspended in hypotonic buffer on ice and deter-
gent was added to 0.5 %. Nuclei were pelleted and resus-
pended in nuclear protein extract buffer (50 mmol/l
HEPES [pH 7.8], 300 mmol/l NaCl, 50 mmol/l KCl,
0.1 mmol/l EDTA, 10 % [v/v] glycerol) on ice for 30 min
and then spun, and the supernatant was saved. Protein
levels in the supernatant were determined using the
BCA method. Aliquots of 30 μg of each protein sample
were resolved by 10 % sodium dodecyl sulfate polyacryl-
amide-gel electrophoresis and transferred to a polyvinyli-
dene fluoride membrane. After transfer, membranes
were blocked with 5 % nonfat dry milk in Tris-buffered
saline and then incubated overnight with primary anti-
bodies at 4°C. After washing, blots were further incu-
bated with 1:2,000 diluted secondary antibodies
including horseradish peroxidase (HRP)-conjugated goat
anti-mouse, goat anti-rabbit, or rabbit anti-goat IgG for
2 h at room temperature. After additional washing, HRPactivity was detected by ECL, according to the manufac-
turer’s instructions.
Quantitation of arterial atherosclerotic lesions
The proximal aortas of apoE−/− mice were immersed in
ice-cold 4 % paraformaldehyde for 30 min. The samples
were then transferred to 30 % sucrose-PBS solution at 4°
C for 24 h, embedded in tissue freezing medium and
snap-frozen in liquid nitrogen. Cryosections (5 μm thick)
were cut from the proximal aortas beginning at the end
of the aortic sinus, and stained with oil red O and
hematoxylin and eosin. Arterial atherosclerotic lesions
were also measured in aortas by en face oil red O stain-
ing. Quantitative analysis of the lesions was performed
using Image Pro Plus software on at least 15 sections
from each animal by an operator who was blinded to
group assignment.
Immunofluorescence staining
SVEC cells were plated on coverslips and incubated at
37°C and 5 % CO2 to allow the cells to adhere and
spread. Serial 5-μm-thick cryosections were cut from the
proximal aortas. Cells or cryosections were fixed with
4 % paraformaldehyde for 20 min. After washing three
times with PBS, cells or cryosections were permeabilized
with 1 % Triton X-100 in PBS for 30 min and blocked
with goat serum for 20 min at room temperature. The
cells were stained with primary antibodies against NF-
κB. The cryosections were incubated with primary anti-
bodies to VCAM-1, ICAM-1 or Mac-3. Alexa Fluor 488,
555, and 568 secondary antibodies (Invitrogen, OR, USA)
were used at concentrations of 1:300. Nuclei were stained
with 4',6-diamidino-2-phenylindole (DAPI). Stained cells
or tissues were observed using the Leica QWN (Wetzlar,
Germany) analysis system.
Assessment of cell viability
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT; Sigma-Aldrich, Saint Louis, MO, USA)
assay is based on the cleavage of MTT by mitochondrial
dehydrogenases, reflecting the cell viability. SVEC cells
were treated with 10 ng/ml TNF-α in the absence or
presence of ARE (30, 60 or 120 μg/ml) for 8 h, followed
by the addition of 0.5 mg/ml MTT medium and incuba-
tion for 4 h at 37°C. The medium was removed and di-
methyl sulfoxide was added. The absorbance was
examined at 570 nm.
Statistical analysis
The data are expressed as mean±SD. All data were ana-
lyzed using SPSS 13.0 statistical software. Differences be-
tween two groups were compared using unpaired
Student’s t-tests. Differences among three or more groups
were compared using one-way analysis of variance
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(two-tailed).Results
ARE inhibits TNF-α-stimulated adhesion of THP-1 cells to
SVEC cells
The number of THP-1 cells adhering to the endothelial
cell monolayer was increased by pretreatment with
10 ng/ml TNF-α for 4 h. However, the TNF-α-stimulated
increase in leukocyte adhesion was reduced almost to
control levels when SVEC cells were treated with 10 ng/
ml TNF-α together with 120 μg/ml ARE, especially after
4–8 h (Figure 1A and B). The MTT assay was used to
exclude the possibility of toxic effects induced by ARE
(Figure 1C). ARE had no influence on cell viability at the
concentrations used. These result demonstrate that the
downregulation of adhesion molecules by ARE in SVEC
cells was not a result of direct toxicity of the substance.ARE inhibits upregulation of VCAM-1 and ICAM-1
expression induced by TNF-α
ELISA assays demonstrated that the expression levels of
soluble VCAM-1 and soluble ICAM-1 in the super-
natant from SVEC cells increased rapidly after exposure
to TNF-α (10 ng/ml) (Figure 2A). Expression levels of
VCAM-1 and ICAM-1 induced by 10 ng/ml TNF-α
were inhibited by co-incubation with different concen-
trations of ARE (30, 60 or 120 μg/ml) in a dose-
dependent manner. The TNF-α-induced VCAM-1 and
ICAM-1 expression levels were inhibited by 61 % and
67 %, respectively, by 120 μg/ml ARE. Preincubation of
SVEC cells with 120 μg/ml ARE for 2, 4, 6, or 8 h
resulted in inhibition of the TNF-α-induced VCAM-1
and ICAM-1 expression levels in a time-dependent
manner. Significant reductions in TNF-α-induced
VCAM-1 and ICAM-1 expression levels were seen in
cells preincubated with ARE for 4–8 h. These results
demonstrate that ARE inhibited the induction of
VCAM-1 and ICAM-1 by TNF-α in dose- and time-
dependent manners.
Western blot analysis showed similar results regarding
the levels of VCAM-1 and ICAM-1 protein expression.
ARE dose-dependently inhibited the TNF-α-induced
increases in VCAM-1 and ICAM-1 protein levels; ARE
120 μg/ml completely abolished TNF-α-induced upre-
gulation of VCAM-1 and ICAM-1 (Figure 2B). Preincu-
bation of SVECs with 120 μg/ml ARE for 2, 4, 6, or 8 h
inhibited TNF-α-induced VCAM-1 and ICAM-1 ex-
pression levels in a time-dependent manner. Significant
reductions in TNF-α-induced VCAM-1 and ICAM-1
expression levels were seen in cells preincubated with
ARE for 4–8 h (Figure 2C).ARE inhibits TNF-α-induced NF-κB activation
To determine if ARE-induced inhibition of adhesion-
molecule expression was mediated by blocking the
p-iκB/NF-κB pathway, the total protein level of p-iκB
and the nuclear protein level of NF-κB p65 were ana-
lyzed by western blotting. The levels of p-iκB and NF-κB
protein increased dramatically following induction by
TNF-α (10 ng/ml). Co-incubation of the cells with dif-
ferent concentrations of ARE at different times pre-
vented iκB phosphorylation and NF-κB activation in
dose- and time-dependent manners. ARE almost com-
pletely abolished TNF-α- induced iκB phosphorylation
and NF-κB activation after preincubation for 4–8 h at
120 μg/ml (Figure 3A and B). Furthermore, immuno-
fluorescence staining demonstrated that ARE could in-
hibit TNF-α-induced translocation of NF-κB to the
nucleus. NF-κB was detected in the cytoplasm in un-
treated control cells or cells treated with ARE alone
(Figure 3C). However, rapid translocation of NF-κB from
the cytoplasm to the nucleus occurred when the cells
were incubated for 4 h with TNF-α (10 ng/ml). This
translocation was significantly inhibited by 120 μg/ml
ARE, and the nucleus remained virtually free of the tran-
scription factor in cells treated with both TNF-α and
ARE.ARE prevents atherosclerosis development in apoE−/−
mice
All apoE−/− mice fed a high-fat, high-cholesterol diet for
16 weeks developed atherosclerotic lesions along the
proximal aortic walls and at the valve cusps. The intima
was markedly thickened with the accumulation of lipids,
macrophages and foam cells. However, ARE-treated
mice showed a significant reduction in atherosclerotic-
plaque-lesion size compared with control mice. The
ratio of plaque area to total vessel area in the ARE mice
was 16.12 ± 1.73 % compared with 31.51 ± 1.92 % in con-
trol mice (P< 0.01) (Figure 4A). In addition, en face oil
red O-stained aortas from apoE−/− mice in both groups
exhibited similar results (Figure 4B). Atherosclerotic
lesions in the aortic root in the control and ARE-treated
apoE−/− mice were immunostained with anti-mouse
macrophage antibody (Mac-3). Macrophage infiltration
into the endothelium was significantly inhibited in ARE-
treated apoE−/− mice (21.34 ± 1.82 %) compared with
control apoE−/− mice (38.4 ± 1.41 %) (Figure 4C).ARE decreases the expression of adhesion molecules in
the endothelium of apoE−/− mice
We investigated the effects of ARE on inflammatory
responses to further clarify the molecular mechanisms
whereby ARE restricts the development of atheroscler-
otic lesions. The levels of adhesion molecules in the
Figure 1 ARE inhibited TNF-α-stimulated adhesion of THP-1 cells to SVEC cells. A, B. Quantitation of THP-1 cells adhering to untreated SVEC
cells and to SVEC cells treated for 4 h with 10 ng/ml TNF-α in the absence or presence of ARE (30, 60 or 120 μg/ml) for up to 2, 4, 6, or 8 h. For
details of the adhesion assay see Materials and methods. The number of adherent THP-1 cells was determined using a counting slide. Data are
representative of at least three independent experiments and are shown as mean values ± S.D. *P< 0.05 compared with cells treated with TNF
alone. Scale bars: 50 μm. C. SVEC cells were treated with 10 ng/ml TNF-α in the absence or presence of ARE (30, 60 or 120 μg/ml) for 8 h. The
viability of SVEC cells was determined by MTT analysis.
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Figure 2 ARE inhibited upregulation of VCAM-1 and ICAM-1 expression induced by TNF-α (ELISA and western blot). Confluent SVEC cells
were incubated with medium or 10 ng/ml TNF-α alone, or with 10 ng/ml TNF-α together with 30, 60 or 120 μg/ml ARE for 4 h. Confluent SVEC
cells were preincubated with 120 μg/ml ARE for 2, 4, 6, or 8 h, and thereafter washed and incubated for 4 h with 10 ng/ml TNF-α. Culture
medium and proteins were collected and analyzed for VCAM-1 and ICAM-1 expression by ELISA and western blot at the time points indicated.
A. ELISA analyses of VCAM-1 and ICAM-1 expression levels in SVEC cells. B. Western blot analyses of VCAM-1and ICAM-1 expression levels in SVEC
cells. VCAM-1 and ICAM-1 levels were normalized to the levels of β-actin.
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fluorescence analysis revealed reduced staining of
VCAM-1 and ICAM-1 in aortic sections from ARE-trea-
ted apoE−/− mice. The relative fluorescence intensities of
VCAM-1 and ICAM-1 in the endothelium of ARE-trea-
ted apoE−/− mice were significantly reduced (Figure 5).
Staining for CD31 showed that the aortic endotheliumremained intact in ARE-treated mice. These results suggest
that ARE inhibited the interaction of inflammatory cells
with endothelial cells.
Discussion
Multiple lines of evidence support the idea that athero-
sclerosis is a chronic inflammatory disease [1]. In China,
Figure 3 ARE inhibited TNF-α induced upregulation of NF-κB expression (western blot) and translocation (immunofluorescence
staining). A. Confluent SVEC cells were incubated with medium or 10 ng/ml TNF-α alone, or with 10 ng/ml TNF-α together with 30, 60 or
120 μg/ml ARE for 4 h. B. Confluent SVEC cells were preincubated with 120 μg/ml ARE for 2, 4, 6, or 8 h, and thereafter washed and incubated for
4 h with 10 ng/ml TNF-α. NF-κB levels were normalized to the levels of β-actin. C. ARE inhibited TNF-α-induced NF-κB translocation from the
cytoplasm to the nucleus in SVEC cells. SVEC cells were cultured on glass coverslips in six-well plates for 2 days, and then incubated with medium
(control), 120 μg/ml ARE, or TNF-α (10 ng/ml) alone, or TNF-α in combination with ARE for 4 h. After stimulation, the cells were washed, fixed and
permeabilized. The cells were then blocked with 2 % bovine serum albumin in PBS solution, and incubated with a mouse monoclonal NF-κB p65
antibody, followed by a second fluorescein isothiocyanate-conjugated antibody. Nuclei were stained with DAPI, and stained cells were assessed
by fluorescence microscopy. Immunofluorescent images shown in a–h are representative of at least three experiments with determinations made
in quadruplicate. a, untreated control cells; b, cells treated with TNF-α (10 ng/ml) alone; c, cells treated with ARE (120 μg/ml) alone; d, cells treated
with TNF-α plus ARE; e–h, nuclei. Scale bars: 10 μm.
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treatment of cardiovascular diseases [20,21], and ARE is
one of the major active ingredients extracted from this
root. Previous studies have revealed that ARE possessesanti-inflammatory and immunoregulatory roles [22]. Fur-
thermore, recent evidence demonstrated that ARE could
reduce macrophage migration [15] and adhesion to
endothelial cells, and relieved local inflammation via the
Figure 4 ARE inhibited progression of established atherosclerotic lesions and accumulation of macrophages in the aorta of apoE−/−
mice. A. Hematoxylin and eosin and oil red O staining of lesions in the aortic root in control and ARE apoE−/− mice (100×). Scale bars: 80 μm.
B. Representative oil red O-stained aortas from apoE−/− mice in both groups. Bar graph shows distribution of intima/lumen ratio. *P< 0.01 vs
control. C. Atherosclerotic lesions in aortic root from control and ARE apoE−/− mice immunostained with anti-mouse macrophage antibody (Mac-
3). Double-immunofluorescence staining (n = 4–5 sections per tissue, at least three sites of analysis per slide). Bar graph shows quantitative
comparison of composition of atherosclerotic lesions between control and ARE-treated groups. Scale bars: 80 μm.
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might have anti-atherosclerotic properties associated
with its anti-inflammatory role. We therefore investi-
gated the effects of ARE on the expression of adhesionmolecules and its anti-inflammatory effects in vitro and
in vivo. ARE inhibited the activation of NF-κB in SVEC
cells in vitro and reduced atherosclerotic-lesion size in
apoE−/− mice fed a high-fat, high-cholesterol diet in vivo.
Figure 5 ARE decreased the expression of adhesion molecules in the endothelium of apoE−/− mice. A. ARE treatment suppressed the
levels of VCAM-1 and ICAM-1 in the aortic endothelium of apoE−/− mice. Double-immunofluorescence staining (n = 4–5 sections per tissue, at
least three sites of analysis per slide). B. The relative fluorescence intensity of VCAM-1 and ICAM-1 in the endothelium of apoE −/− mice. *P< 0.01
vs control. Scale bars: 80 μm.
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the expression of adhesion molecules in endothelial cells
and the adhesion of circulating leukocytes to the acti-
vated endothelium [23,24]. The current study found that
pretreatment of SVEC cells with ARE almost abolished
TNF-α-induced adhesion of monocytic THP-1 cells to
endothelial cells. ARE could reduce TNF-α-induced
upregulation of VCAM-1 and ICAM-1 expression levels
in dose- and time-dependent manners, suggesting that
ARE might be able to block leukocyte adhesion in vitro
completely. Co-treatment of SVEC cells with TNF-α and
ARE resulted in dose- and time-dependent decreases in
adhesion molecules accompanied by a significant de-
crease in p-iκB expression and inhibition of NF-κBactivation. NF-κB binds to specific sites in the promoter
region of target genes and apparently mediates TNF-α-
induced activation of endothelial cells by transiently indu-
cing the genes coding for adhesion molecules [25,26] and
atherosclerosis [27-31]. ARE dose- and time-dependently
inhibited TNF-α-induced upregulation of NF-κB and p-iκB
expression, indicating that it interfered with the NF-κB
pathway by inhibiting TNF-α-induced degradative phos-
phorylation of iκB, an inhibitor of NF-κB, which binds to
the transcription factor in the cytosol, thereby preventing
its translocation to the nucleus [32]. The current results
showed that ARE at 120 μg/ml could completely inhibit
TNF-α-induced NF-κB nuclear translocation. Selective in-
hibition of NF-κB activation by ARE would therefore affect
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that ARE regulated VCAM-1 and ICAM-1 expression
levels through down-regulation of the NF-κB pathway in
SVEC cells.
To further elucidate the impact of ARE on atheroscler-
osis, we investigated its effects in apoE−/− mice fed on an
atherogenic diet. ApoE−/− mice are created by targeted
gene inactivation, and are considered to be a relevant
model for atherosclerosis because they are hypercholes-
terolemic and develop spontaneous arterial lesions [33].
ApoE−/− mice treated with ARE had significantly smaller
aortic sinus lesions, lower numbers of macrophages in
the aortic wall, and decreased expression levels of adhe-
sion molecules (VCAM-1 and ICAM-1) in the vessel
wall compared with control mice. In conclusion, ARE
could prevent the formation of atherosclerosis by regu-
lating the expression of adhesion molecules in aortas of
apoE−/− mice.
Conclusions
In conclusion, the results of this study demonstrate that
ARE has the capacity to protect the aorta from athero-
sclerosis, potentially via an anti-inflammatory mechanism.
To the best of our knowledge, this is the first study to re-
veal a possible role for ARE in the treatment of athero-
sclerosis. One of the major mechanisms of ARE action
appears to be through regulating the levels of adhesion
molecule expression in endothelial cells via the NF-κB
pathway. These findings suggest an anti-atherosclerotic ef-
fect of ARE and support its potential clinical use for the
treatment of atherosclerosis.
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